Andrew P. Garner

1.6k total citations
41 papers, 1.0k citations indexed

About

Andrew P. Garner is a scholar working on Oncology, Molecular Biology and Surgery. According to data from OpenAlex, Andrew P. Garner has authored 41 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 16 papers in Molecular Biology and 8 papers in Surgery. Recurrent topics in Andrew P. Garner's work include Drug Transport and Resistance Mechanisms (10 papers), Helicobacter pylori-related gastroenterology studies (8 papers) and Gastroesophageal reflux and treatments (5 papers). Andrew P. Garner is often cited by papers focused on Drug Transport and Resistance Mechanisms (10 papers), Helicobacter pylori-related gastroenterology studies (8 papers) and Gastroesophageal reflux and treatments (5 papers). Andrew P. Garner collaborates with scholars based in United Kingdom, United States and United Arab Emirates. Andrew P. Garner's co-authors include Gunnar Flemström, Jon R. Heylings, Egle Avizienyte, Richard A. Ward, Mark J. I. Paine, David G. Tew, C. Roland Wolf, Simon J. Cook, Kathryn Balmanno and Claire R. Weston and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Gastroenterology.

In The Last Decade

Andrew P. Garner

40 papers receiving 968 citations

Peers

Andrew P. Garner
Daisuke Yasuda Japan
Cristina Nogueira United States
Haruo Taniguchi Japan
Jong‐Shiaw Jin Taiwan
Ornella Fantappiè Italy
Kiyomu Fujii Japan
H. Mutoh Japan
Xiang Shen China
Ki Beom Bae South Korea
Weihua Qiu China
Daisuke Yasuda Japan
Andrew P. Garner
Citations per year, relative to Andrew P. Garner Andrew P. Garner (= 1×) peers Daisuke Yasuda

Countries citing papers authored by Andrew P. Garner

Since Specialization
Citations

This map shows the geographic impact of Andrew P. Garner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew P. Garner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew P. Garner more than expected).

Fields of papers citing papers by Andrew P. Garner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew P. Garner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew P. Garner. The network helps show where Andrew P. Garner may publish in the future.

Co-authorship network of co-authors of Andrew P. Garner

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew P. Garner. A scholar is included among the top collaborators of Andrew P. Garner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew P. Garner. Andrew P. Garner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Garner, Andrew P., et al.. (2025). Autonomic modulation and skeletal muscle oxygenation with intermittent low-load blood flow restriction knee extension. Frontiers in Sports and Active Living. 7. 1515412–1515412.
2.
Garner, Andrew P., Joseph M. Gozgit, Rana Anjum, et al.. (2014). Ponatinib Inhibits Polyclonal Drug-Resistant KIT Oncoproteins and Shows Therapeutic Potential in Heavily Pretreated Gastrointestinal Stromal Tumor (GIST) Patients. Clinical Cancer Research. 20(22). 5745–5755. 123 indexed citations
3.
Allen, Joanne V., Catherine Bardelle, Kevin Blades, et al.. (2011). The discovery of benzanilides as c-Met receptor tyrosine kinase inhibitors by a directed screening approach. Bioorganic & Medicinal Chemistry Letters. 21(18). 5224–5229. 9 indexed citations
4.
Bright, Michael D., Andrew P. Garner, & Anne J. Ridley. (2009). PAK1 and PAK2 have different roles in HGF-induced morphological responses. Cellular Signalling. 21(12). 1738–1747. 34 indexed citations
5.
Garner, Andrew P., et al.. (2009). Experimental and numerical nano-characterisation of two phases in concrete. International Journal of Materials and Structural Integrity. 3(2/3). 134–134. 8 indexed citations
6.
Wells, Claire M., et al.. (2008). ROCK1 and LIMK2 Interact in Spread but Not Blebbing Cancer Cells. PLoS ONE. 3(10). e3398–e3398. 17 indexed citations
7.
Avizienyte, Egle, Richard A. Ward, & Andrew P. Garner. (2008). Comparison of the EGFR resistance mutation profiles generated by EGFR-targeted tyrosine kinase inhibitors and the impact of drug combinations. Biochemical Journal. 415(2). 197–206. 74 indexed citations
8.
Molton, Sarah A, Claire R. Weston, Kathryn Balmanno, et al.. (2005). The conditional kinase ΔMEKK1:ER* selectively activates the JNK pathway and protects against serum withdrawal-induced cell death. Cellular Signalling. 17(11). 1412–1422. 3 indexed citations
9.
Todd, Daniel E., Ruth M. Densham, Sarah A Molton, et al.. (2004). ERK1/2 and p38 cooperate to induce a p21CIP1-dependent G1 cell cycle arrest. Oncogene. 23(19). 3284–3295. 74 indexed citations
10.
Garner, Andrew P., Claire R. Weston, Daniel E. Todd, Kathryn Balmanno, & Simon J. Cook. (2002). ΔMEKK3:ER* activation induces a p38α/β2-dependent cell cycle arrest at the G2 checkpoint. Oncogene. 21(53). 8089–8104. 45 indexed citations
11.
Paine, Mark J. I., Andrew P. Garner, David J. Powell, et al.. (2000). Cloning and Characterization of a Novel Human Dual Flavin Reductase. Journal of Biological Chemistry. 275(2). 1471–1478. 75 indexed citations
12.
Garner, Andrew P., Mark J. I. Paine, Ignacio Rodríguez‐Crespo, et al.. (1999). Nitric oxide synthases catalyze the activation of redox cycling and bioreductive anticancer agents.. PubMed. 59(8). 1929–34. 95 indexed citations
13.
Bailey, Tom, et al.. (1998). Drug metabolizing enzyme systems in the houbara bustard (Chlamydotis undulata). Comparative Biochemistry and Physiology Part C Pharmacology Toxicology and Endocrinology. 120(3). 365–372. 4 indexed citations
14.
Adeghate, Ernest, et al.. (1998). Age-related changes in morphology and secretory responses of male rat lacrimal gland. Journal of the Autonomic Nervous System. 69(2-3). 173–183. 43 indexed citations
15.
Garner, Andrew P., et al.. (1997). Pantoprazole: a new and more specific proton pump inhibitor. Expert Opinion on Investigational Drugs. 6(7). 885–893. 6 indexed citations
16.
Bastaki, Salim M. A., et al.. (1995). Effects of anaesthetic agents on basal and histamine-stimulated acid secretion in the fistula rat. European Journal of Gastroenterology & Hepatology. 12(7). 1199–1202. 10 indexed citations
17.
Garner, Andrew P., et al.. (1991). Location and characteristics of epidermal growth factor binding to enterocyte plasma membranes. Biochemical Society Transactions. 19(3). 307S–307S. 3 indexed citations
18.
Camble, Roger, et al.. (1990). Design and synthesis of bombesin/gastrin-releasing peptide antagonists. Biochemical Society Transactions. 18(6). 1294–1296. 1 indexed citations
19.
20.
Heylings, Jon R., Andrew P. Garner, & Gunnar Flemström. (1982). The Gastric “Mucus-Bicarbonate” Barrier: Effect of Luminal Acid on HCO 3 - Transport by Amphibian Fundic Mucosa In Vitro. Advances in experimental medicine and biology. 144. 183–185. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daisuke Yasuda Breakdown of academic impact, for papers by Cristina Nogueira Breakdown of academic impact, for papers by Haruo Taniguchi Breakdown of academic impact, for papers by Jong‐Shiaw Jin Breakdown of academic impact, for papers by Ornella Fantappiè Breakdown of academic impact, for papers by Kiyomu Fujii Breakdown of academic impact, for papers by H. Mutoh Breakdown of academic impact, for papers by Xiang Shen Breakdown of academic impact, for papers by Ki Beom Bae Breakdown of academic impact, for papers by Weihua Qiu
Rankless by CCL
2026